$1.235
-0.015 (-1.20%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MTNB Prediction & Forecast by Similar Chart Analysis
Alphio's MTNB stock price prediction model matches the current Matinas BioPharma Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.26 (+1.99%). The 1-week path is $1.33 (+7.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Matinas BioPharma Holdings Inc Stock?
Matinas BioPharma Holdings Inc is not a good buy right now. The current price is $1.25, with an RSI of 25.709 indicating oversold conditions, but the company has reported a staggering year-to-date change of -86.56% and a negative forward P/E ratio of 0, reflecting a lack of profitability and growth potential. Additionally, the company faces delisting risk from the NYSE due to insufficient shareholder equity, which is currently at $1.8 million, below the required $2 million. This financial instability poses a significant risk for investors.
MTNB stock price ended at $1.24 on Monday, after losing -1.20%
Matinas BioPharma Holdings Inc (MTNB) last closed at $1.235, losing -1.20%. These facts feed the 1-day and 1-week MTNB price prediction above.
Analyst Consensus
Matinas BioPharma Holdings Inc (MTNB): 3 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Matinas BioPharma Holdings Inc (MTNB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MTNB, ranked by similarity.
Seasonality analysis for MTNB
Historically the probability of a positive November return for MTNB is 42.22%. June offers the highest probability of a positive month at 65.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MTNB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.84 | $0.86 | $1.08 | -30.62% |
| Dec 2026 | $0.95 | $1.00 | $1.12 | -18.85% |
In 2026, Matinas BioPharma Holdings Inc (MTNB) is projected to range from $0.84 to $1.12.
Matinas BioPharma Holdings Inc 2026 monthly forecast
In Nov 2026, Matinas BioPharma Holdings Inc is projected to average $0.86, with a low of $0.84 and high of $1.08.
In Dec 2026, Matinas BioPharma Holdings Inc is projected to average $1.00, with a low of $0.95 and high of $1.12.
Related articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.